Self-Injectable for SLE Gets FDA Nod
July 21st 2017Officials with GSK announced that the US FDA has approved a new subcutaneous formulation of belimumab (Benlysta) for the treatment of adult patients with active, autoantibody‑positive systemic lupus erythematosus (SLE) who are receiving standard therapy.
Read More
CDC Report Notes That More than 100 Million Americans Have Diabetes, Prediabetes
July 21st 2017The National Diabetes Statistics Report, released approximately every 2 years, provides information on diabetes prevalence and incidence, prediabetes, risk factors for complications, acute and long-term complications, mortality, and costs in the United States.
Read More